Oragenics Announces Pricing of $12.5 Million Underwritten Public Offering
TAMPA, Fla.–(BUSINESS WIRE)–Oragenics, Inc. (NYSE American: OGEN), a leader in the development of new antibiotics against infectious diseases and effective…
Pharmaceuticals, Biotechnology and Life Sciences
TAMPA, Fla.–(BUSINESS WIRE)–Oragenics, Inc. (NYSE American: OGEN), a leader in the development of new antibiotics against infectious diseases and effective…
–Study will test efficacy and safety of novel docetaxel-based oral therapeutic– AMSTERDAM–(BUSINESS WIRE)–Modra Pharmaceuticals B.V. (“Modra”) today announced that the…
A win in all six core categories affirms Vetter as a trusted solution provider Vetter performs very well in customer-critical…
Minneapolis, Chicago and Cleveland lead the pack in investment, while the number of Midwest companies receiving funding increases 20% CLEVELAND–(BUSINESS…
OSS, The Netherlands–(BUSINESS WIRE)–Lead Pharma, a pharmaceutical company developing innovative medicines for the treatment of immunological and oncological indications, today…
DUBLIN–(BUSINESS WIRE)–The “Clinical Trial Management System Market – Forecasts from 2019 to 2024” report has been added to ResearchAndMarkets.com’s offering.…
BOSTON–(BUSINESS WIRE)–Gelesis, a biotechnology company developing first-in-class mechanotherapeutics to treat obesity and other chronic diseases related to the gastrointestinal (GI)…
Minneapolis, Chicago and Cleveland lead the pack in investment, while the number of Midwest companies receiving funding increases 20% CLEVELAND–(BUSINESS…
WATERTOWN, Mass.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/CEO?src=hash" target="_blank"gt;#CEOlt;/agt;–FORMA Therapeutics announced today the appointment of Frank D. Lee as Chief Executive Officer, starting on…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Aura Biosciences, a leader in the development of novel targeted therapies in ocular oncology, today announced that interim…